Clifton Allred, APRN
Psychiatric/Mental Health · Memphis, TNNPI 1265030175
Payments from drug & device makers
Across 285 payments — averaging $16.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$594
- Alkermes, Inc.$399
- Otsuka America Pharmaceutical, Inc.$377
- Lundbeck LLC$286
- Ironshore Pharmaceuticals Inc.$240
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,714100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,159 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $594 |
| Alkermes, Inc. | 19 | $399 |
| Otsuka America Pharmaceutical, Inc. | 22 | $377 |
| Lundbeck LLC | 16 | $286 |
| Ironshore Pharmaceuticals Inc. | 30 | $240 |
| Tris Pharma Inc | 14 | $226 |
| Neurocrine Biosciences, Inc. | 13 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $161 |
| Johnson & Johnson | 7 | $150 |
| Axsome Therapeutics, Inc. | 6 | $133 |
| Indivior Inc. | 7 | $119 |
| Supernus Pharmaceuticals, Inc. | 6 | $105 |
| Sunovion Pharmaceuticals Inc. | 5 | $99 |
| Idorsia Pharmaceuticals US Inc | 5 | $88 |
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Bausch Health US, LLC | 3 | $54 |
| Merck | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Corium, LLC | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Noven Therapeutics, LLC | 2 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$117
How this compares
$4,714 in reported general payments places this provider in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $485 |
| Duloxetine Hcl | 22 | $431 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $206 |
| Buspirone Hcl | 12 | $125 |
| Risperidone | 20 | $108 |
| Hydroxyzine Pamoate | 17 | $104 |
| Trazodone Hcl | 17 | $50 |
| Lamotrigine | 11 | $44 |
| Escitalopram Oxalate | 31 | $38 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $32 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Memphis
- Mary AllenMemphis$422K
- Sarah VogelfangerMemphis$94K
- Michael HobbsMemphis$23K
- Angela HammondMemphis$16K
- Kristen LockeMemphis$9K
- Latasha GarrettMemphis$8K
- Lisa WilliamsMemphis$8K
- Kristin FitchpatricMemphis$8K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.